(Hypertension. 2001;37:1351.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Cardiology (K.S.), Internal Medicine (G.N., I.O., M.R.), and Research Forum (M.R.), Ullevål University Hospital, Oslo, Norway; and Department of Internal Medicine, University Hospital of Groningen (J.D.L., M.M., R.O.B.G., A.J.S.), The Netherlands.
Correspondence to Knut Sevre, MD, Department of Cardiology, Ullevål University Hospital, N-0407 Oslo, Norway. E-mail knut.sevre{at}ioks.uio.no
| Abstract |
|---|
|
|
|---|
Key Words: hypertension gender baroreflex catecholamines heart rate
| Introduction |
|---|
|
|
|---|
HRV, which estimates the tonic HR control,11 12 13 is generally reduced (standard deviation of all R-R intervals [SDNN] and total power [energy in the heart period spectrum between 0.0033 and 0.40 Hz] [TP]) in hypertensive patients.2 4 5 6 Markers of sympathetic predominance are increased in some3 but not all studies.4 5 6
BRS, which estimates the reflex vagal HR control,11 12 13 is reduced in hypertensive subjects.6 7 8 9 10 Both BRS and HRV parameters (except low frequency power [energy in the heart period spectrum between 0.04 and 0.15 Hz] [LF]/high frequency power [energy in the heart period spectrum between 0.15 and 0.40 Hz] [HF]) decrease with increasing age in healthy10 14 and hypertensive subjects.10 It is also proposed that BRS stabilizes after middle age.8
There may be gender differences in the pathophysiology of essential hypertension. We have previously observed that hypertensive women have low-renin hypertension15 and less cardiovascular reactivity to stress compared with hypertensive men.16 However, thus far there has been only 1 specific study on possible gender differences in HRV in hypertension,4 and there have been none on BRS. Singh et al4 found reduced LF/HF ratio but not TP, percentage of adjacent R-R intervals differing >50 ms (PNN50), square root of the mean of the sum of the squares of differences between adjacent R-R intervals (RMSSD), LF, and HF in hypertensive women compared with hypertensive men.
However, there are more studies on gender differences in
healthy subjects.
SDNN,4 17 18
LF/HF ratio, and LF normalized units
[LF/(LF+HF)x100]4 17 19
have been found lower and HF normalized units
[HF/(LF+HF)x100]17 and
HF4 17 19
have been found higher in women than in men. Moreover, BRS is reduced
in women compared with
men,14 17 18 20
but the difference is not significant in those age
60
years.14
In both healthy and hypertensive subjects, previous studies suggest a higher tonic parasympathetic activity in women than in men. Surprisingly, these studies also propose decreased reflex vagal responses in healthy women compared with healthy men. However, the correlation between HRV and BRS is weak.12
While gender differences in HRV and BRS have been studied in healthy subjects, no one has addressed specifically gender differences in BRS in hypertensive patients compared with normotensive controls. This article presents some new findings suggesting that autonomic dysfunction may play a more prominent role in female than in male hypertension.
| Methods |
|---|
|
|
|---|
140 and
180 mm Hg, diastolic BP
90
mm Hg). Patients were excluded if secondary hypertension was
suspected, if they had recently suffered from a
cardiovascular event, if organ failure was present,
or if they had diabetes mellitus, autoimmune disease, or Parkinsons
disease. Use of neuroleptics, antidepressants, lithium,
antiarrhythmics, and cimetidine was not allowed. These criteria were
similar for the normotensive controls except for their BP level, which
had to be <140/90 mm Hg. Patients were recruited from the outpatient clinic for hypertensive patients, Ullevål University Hospital, Oslo, Norway, and the University Hospital of Groningen, Netherlands. Normotensive controls were partly former participants in a screening program for cardiovascular risk factors. The subjects entered the study between September 1996 and February 1999. All patients gave written informed consent. The regional ethical research committees in both countries approved the protocol. Baseline characteristics at inclusion are summarized in Tables 1 and 2.
|
|
Study Procedure
All subjects were examined at 2 visits. At the first
visit, patients were advised to stop taking any antihypertensive drugs.
The patients who terminated antihypertensive medication were scheduled
for BP control once a week after the first visit. At 4 weeks after the
first visit, the second visit, the final assessment of eligibility, was
performed.
All examinations were performed in the morning in a quiet room with temperature 22°C to 24°C. The subjects were examined after an overnight fast and had refrained from alcohol and tobacco for at least the last 24 hours. HR and sitting sphygmomanometric BP were measured after 10 minutes of rest. Beat-to-beat BP and HR were recorded with the patient in the supine position with a Finapres (Ohmeda 2300) noninvasive BP monitor with the appropriate cuff applied to the third finger of the left hand. This instrument has been validated, and the accuracy and precision have been found sufficient for tracking of changes in BP and HR.21 A 24-hour Holter ECG was applied to the chest (Marquette series 8500).
Because mental stress can influence autonomic functions, the purpose of visit 1 was to familiarize the patient with the study procedure. Thus, only data from the second visit are presented.
HRV Analysis
Twenty-fourhour ambulatory ECG recordings
were analyzed on a Marquette laser Holter system (series
8000XP). HRV was analyzed as described
previously22 and in
accordance with international
guidelines.23 Three ECG
leads (modified leads V1,
V5, and aVF) and a time signal to correct for
tape speed irregularities were recorded. The 24-hour
recordings were divided into 288 segments of 5 minutes. Twelve
5-minute segments were averaged to obtain hourly mean values of the HRV
parameters. All ectopic beats were classified, and only
segments with <15% ectopy were used. Each nonnormal R-R interval was
substituted by the subsequent R-R interval. Two experienced Holter
analysts, with supervision of a cardiologist, analyzed all
recordings. Normalized units, TP, LF, and HF have been defined
previously in this report.
BRS Measurement
Finapres recordings of 8 segments of 300
seconds of beat-to-beat BP and HR during rest in the supine position
were used for determination of the BRS with the CARSPAN program
(ProGAMMA bv), as described
previously.7 24 25
This program allows discrete Fourier transformation of nonequidistant
samples of BP and R-R interval series. The signals were tested for
stationarity, and artifacts were corrected. Nonstationary signals or
periods with >10% correction were excluded. Segments that lasted
<100 seconds after this procedure were excluded. Subsequently,
spectral analysis of systolic BP and R-R interval
length was performed, and BRS was calculated by the transfer function
method. This method defines the BRS as the mean modulus between
systolic BP and R-R interval length spectra in the midfrequency
band (0.07 to 0.14 Hz) with a coherence of >0.5. BRS is expressed in
ms/mm Hg. A BRS of 10 ms/mm Hg indicates that a rise of 1 mm Hg
in systolic BP will induce 10 ms of R-R interval
lengthening.
Statistical Analysis
On the basis of previous
studies,7 9 we
expected a possible difference in BRS of 3 ms/mm Hg between
normotensive and hypertensive subjects. With a possible SD of 3
ms/mm Hg, at least 15 patients and 15 controls should be examined with
a power of 80%. Because we also planned a subgroup analysis
based on gender differences, however, we included more than twice as
many subjects in both groups. The data were analyzed with the
use of SPSS 9.0.1 statistical package (SPSS Inc). Nonnormal distributed
data were natural log transformed. Two-tailed statistical
analyses of data were performed with Students
t test
(P) and Pearsons correlation
coefficient (r). Stepwise
multiple regression analysis was performed with gender, BP
group (hypertensive or normotensive), age, body mass index (BMI),
smoking status, triglyceride, and total and HDL
cholesterol as predictors and HRV parameters
and BRS as dependent variables. Data are presented as
mean±SEM. The level of statistical significance was set at
P=0.05.
| Results |
|---|
|
|
|---|
Differences Between Hypertensive and
Normotensive Subjects
BRS was reduced in the hypertensive patients
compared with the normotensive controls (7.6±0.6 versus 10.4±0.8
ms/mm Hg, respectively;
P=0.005).
Gender Differences
Hypertensive women had lower BRS than normotensive
women. The difference in BRS between male hypertensive and normotensive
subjects did not reach statistical significance. Female hypertensive
subjects had lower BRS than male hypertensives. BRS did not differ
significantly between the 2 normotensive groups
(Figure 1). BRS correlated with age in the hypertensive and
normotensive male groups
(r=-0.65 and
r=-0.61, respectively;
P
0.01) but not in the female
groups. In the female hypertensive group only, we found a significant
correlation between systolic BP and BRS
(r=-0.51;
P=0.04).
|
Multiple Regression Analysis
Gender, age, and presence of hypertension were the only
significant independent explanatory variables of BRS. BRS decreased
with increasing age and was lower in female and hypertensive
subjects than in men and normotensive subjects
(Table 3).
|
Heart Rate Variability
Seventy-five 24-hour ECG recordings were
analyzed. All had at least 18-hour recordings suitable
for HRV analysis.
Differences Between Hypertensive and
Normotensive Subjects
PNN50, RMSSD, TP, LF, and HF were lower in the
hypertensive group than in the normotensive group. We did not find any
significant differences in normalized units or LF/HF ratio between the
hypertensive and normotensive subjects, although there was a
nonsignificant tendency of higher LF/HF ratio in the hypertensive group
(Table 4).
|
Gender Differences
Hypertensive women had higher HF normalized units
and lower LF normalized units and LF/HF ratio than hypertensive men.
Similar gender differences were found in the normotensive groups. The
hypertensive women had significantly lower TP and LF than the
hypertensive men
(Figures 2 and 3). There were significant differences between
hypertensive and normotensive women in the same parameters
as seen between the entire hypertensive and entire normotensive group
(Figures 2 and 3). We did not find any significant differences
between hypertensive and normotensive men in any of the HRV
parameters.
|
|
Multiple Regression Analysis
Age, gender, HDL cholesterol, and presence
of hypertension were the only significant independent explanatory
variables of HRV numerical values, ie, the variability decreased
with increasing age and was blunted in hypertensive subjects and women
as opposed to normotensive subjects and men. HRV increased with
increasing HDL concentrations. The normalized units of HF and LF were
only related to HDL cholesterol, ie, the higher the HDL
concentrations were, the lower were LF normalized units and the higher
were HF normalized units. LF/HF ratio was related to both HDL and age,
ie, LF/HF ratio decreased with increasing HDL and age
(Table 3).
Hemoglobin, Hematocrit, Creatinine,
and Blood Lipids
Differences Between Hypertensive and
Normotensive Subjects
HDL cholesterol was higher in the
hypertensive than in the normotensive group. We did not find any
statistically significant differences in hematocrit,
creatinine, total cholesterol, or
triglycerides
(Table 1).
Gender Differences
Hypertensive men had higher HDL than normotensive men.
There were no statistically significant HDL differences between the 2
female groups. Female normotensive subjects had higher HDL
(P<0.0005) than male
normotensive subjects. Creatinine and hematocrit was higher
in the male group than in the female group
(P
0.001). We did not find any
gender differences in cholesterol and
triglyceride
(Table 2).
| Discussion |
|---|
|
|
|---|
In addition, we found significantly reduced TP, LF, PNN50, and RMSSD in hypertensive patients compared with normotensive controls. In our subgroup analysis these differences were only observed in the women and not in the men.
LF normalized units and LF/HF ratio were higher in men than in women in both BP groups. By multiple regression analysis, gender, age, and BP were independent determinants of BRS and HRV, TP, LF, HF, PNN50, and RMSSD. High HDL was associated with high values of HRV with the exception of LF normalized units and LF/HF ratio, which were negatively correlated. Thus, in the present study we have demonstrated substantial changes in the autonomic function in hypertensive patients. Moreover, autonomic dysfunction seems to play a more prominent role in female than in male hypertension.
The 4 groups were well matched with respect to gender, smoking, BMI, and age, making our subgroup analyses feasible without any confounding factors.
BRS was calculated with the transfer technique, which utilizes the spontaneous fluctuations in systolic BP and HR mainly induced by the respiration to estimate the BRS. It does not interfere with any cardiovascular control mechanisms26 and correlates well with the phenylephrine ramp method in healthy24 and hypertensive subjects.7
Our BRS results confirm the findings of reduced BRS in hypertensive patients.6 7 8 9 10 BRS did not differ between normotensive men and women. This is in accordance with Laitinen et al,14 who did not find any difference between healthy postmenopausal female subjects aged 60 to 77 years and male age-matched subjects.
Our finding of a substantial reduction of BRS, especially in female hypertension, warrants some comments. Rapid changes in HR following alterations in BP are mediated by the baroreceptor reflex arc, which is an important part of hemodynamic homeostasis. It has been suggested that hypertension is associated with a resetting of the reflex arc at a higher set point.27 Female sex hormones may also be important in modeling female arteries. The compliance of the brachial artery is higher in women than in men.28 Pregnant women have thinner arterial intima layer and thicker media layer than controls.29 Estrogen therapy alone or in combination with simvastatin improves flow-mediated dilation of the brachial artery.30 Interestingly, estrogen alone also increases HDL cholesterol concentrations.30 These studies propose that female sex hormones model the arterial layers, which are crucial to the arterial BP buffer capacity and hence blood pressure variability and BRS. Furthermore, estrogen replacement therapy increases BRS in postmenopausal healthy women.17 In our study all but 1 woman were postmenopausal, and BRS did not differ significantly between the male and the female normotensive groups. Arteriosclerotic plaques may mechanically cause arterial rigidity and consequently decrease BRS.8 It is unlikely, however, that the women in our hypertensive group have more arteriosclerotic changes than their male counterparts. BRS is also lower in hypertensive subjects with insulin resistance than in hypertensive subjects with normal insulin tolerance.6 Our study lacks data regarding insulin resistance, but there were no significant differences in BMI between the 4 groups, nor did any subjects suffer from diabetes. For these reasons we find it unlikely that different sex hormone concentrations, arteriosclerotic changes, or insulin resistance can explain our results. Moreover, the close relationship between BRS and BP only in hypertensive women supports the assumption that autonomic dysfunction may play a more important role in female hypertension.
The HRV differences between hypertensive and normotensive subjects demonstrated in the present study are in accordance with previous studies on HRV regarding the reduction in TP, HF, LF,2 4 5 6 and PNN50.2 We found a small and nonsignificant increase in the LF/HF ratio and LF normalized units in the hypertensive group compared with the normotensive group. This is in accordance with Pikkujamsa et al6 but not with Guzzetti et al,3 who demonstrated significantly increased LF normalized units in the hypertensive group, and Huikuri et al,5 who displayed decreased LF/HF ratio in the hypertensive group. Our subjects were examined twice, whereas Guzzetti et al only examined their subjects once. This may explain the diverging results. Most probably, the responses to the laboratory examination per se will differ between the first and second examinations.31 The subjects in the study by Huikuri et al5 were using vasoactive drugs at the time of the examination, which may have influenced the results. As demonstrated by other investigators,4 17 19 we found higher PNN50, LF/HF ratio, and LF normalized units in male normotensives than in female normotensives. We also confirmed the results of Singh et al4 regarding PNN50, RMSSD, and LF/HF ratio in hypertensive men compared with hypertensive women, but, in contrast, we did not find any significant HRV discrepancies between the male hypertensive and normotensive groups. The probability of type II errors should be considered.
The reduction of overall HRV in hypertensive patients is more pronounced in women than in men. On the other hand, the relative HRV parameters, ie, normalized units and the LF/HF ratio, did not reveal any significant differences between the normotensive and hypertensive subjects in either the male or the female group. We can only speculate as to possible explanations of these results. One interpretation could be a generally more pronounced withdrawal of autonomic HR control in hypertensive women than in hypertensive men, even though the balance between the sympathetic and parasympathetic nervous system is similar. This assumption is further supported by the BRS results, which suggest less HR responsiveness to changes in systolic BP in hypertensive women compared with hypertensive men and normotensive subjects.
During the past decade, BRS has proven to be a powerful independent marker of increased risk for malignant cardiac arrhythmias and sudden death after myocardial infarction.12 32 HRV measurements have also been investigated as predictors of cardiovascular morbidity. However the results have been diverging. While TP,33 ultra low frequency power,33 very low frequency power,33 and SDNN32 have proven to be independent markers of cardiovascular morbidity, the results regarding HF and LF have been less convincing.33 We still lack a physiological understanding of the former HRV parameters, beyond that they reflect a general variability.23 33 Conversely, the physiological basis for the latter is better understood.23
On the basis of reports in patients with other kinds of cardiovascular diseases,12 32 33 however, we might anticipate an association between low BRS and reduced HRV with cardiovascular morbidity in hypertensive subjects as well. On the basis of these considerations, our findings may imply that hypertensive women are more susceptible to cardiac events and arrhythmias than hypertensive men. No long-term studies, however, have been performed to investigate this possibility.
| Acknowledgments |
|---|
Received November 1, 2000; first decision December 12, 2000; accepted December 22, 2000.
| References |
|---|
|
|
|---|
2. Chakko S, Mulingtapang RF, Huikuri HV, Kessler KM, Materson BJ, Myerburg RJ. Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease. Am Heart J. 1993;126:13641372.[Medline] [Order article via Infotrieve]
3. Guzzetti S, Piccaluga E, Casati R, Cerutti S, Lombardi F, Pagani M, Malliani A. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. J Hypertens. 1988;6:711717.[Medline] [Order article via Infotrieve]
4.
Singh JP,
Larson MG, Tsuji H, Evans JC, ODonnell CJ, Levy D. Reduced heart rate
variability and new-onset hypertension: insights into pathogenesis of
hypertension: the Framingham Heart Study.
Hypertension. 1998;32:293297.
5. Huikuri HV, Ylitalo A, Pikkujamsa SM, Ikaheimo MJ, Airaksinen KE, Rantala AO, Lilja M. Heart rate variability in systemic hypertension. Am J Cardiol. 1996;77:10731077.[Medline] [Order article via Infotrieve]
6. Pikkujamsa SM, Huikuri HV, Airaksinen KE, Rantala AO, Kauma H, Lilja M, Savolainen MJ, Kesaniemi YA. Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens. 1998;11:523531.[Medline] [Order article via Infotrieve]
7.
Watkins LL,
Grossman P, Sherwood A. Noninvasive assessment of baroreflex control in
borderline hypertension: comparison with the phenylephrine
method. Hypertension. 1996;28:238243.
8.
James MA,
Robinson TG, Panerai RB, Potter JF. Arterial
baroreceptor-cardiac reflex sensitivity in the elderly.
Hypertension. 1996;28:953960.
9.
Grassi G,
Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of
sympathetic nerve activity in essential and secondary hypertension.
Hypertension. 1998;31:6872.
10. Korner PI, West MJ, Shaw J, Uther JB. "Steady-state" properties of the baroreceptor-heart rate reflex in essential hypertension in man. Clin Exp Pharmacol Physiol. 1974;1:6576.[Medline] [Order article via Infotrieve]
11. La Rovere MT. Autonomic markers of prognosis after myocardial infarction. Clin Sci (Colch). 1996;91(suppl):133135.
12.
Hohnloser
SH, Klingenheben T, van de Loo A, Hablawetz E, Just H, Schwartz PJ.
Reflex versus tonic vagal activity as a prognostic
parameter in patients with sustained
ventricular tachycardia or
ventricular fibrillation.
Circulation. 1994;89:10681073.
13. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Circulation. 1992;85(suppl I):I-77I-99.
14.
Laitinen T,
Hartikainen J, Vanninen E, Niskanen L, Geelen G, Lansimies E. Age and
gender dependency of baroreflex sensitivity in healthy subjects.
J Appl Physiol. 1998;84:576583.
15. Nordby G, Os I, Kjeldsen SE, Eide I. Mild essential hypertension in nonobese premenopausal women is characterized by low renin. Am J Hypertens. 1992;5:579584.[Medline] [Order article via Infotrieve]
16. Mundal HH, Nordby G, Lande K, Gjesdal K, Kjeldsen SE, Os I. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women. Scand J Clin Lab Invest. 1993;53:585591.[Medline] [Order article via Infotrieve]
17.
Huikuri HV,
Pikkujamsa SM, Airaksinen KEJ, Ikaheimo MJ, Rantala AO, Kauma H, Lilja
M, Kesaniemi YA. Sex-related differences in autonomic modulation of
heart rate in middle-aged subjects.
Circulation. 1996;94:122125.
18. Convertino VA. Gender differences in autonomic functions associated with blood pressure regulation. Am J Physiol. 1998;275(pt 2):R1909R1920.
19. Ryan SM, Goldberger AL, Pincus SM, Mietus J, Lipsitz LA. Gender- and age-related differences in heart rate dynamics: are women more complex than men? J Am Coll Cardiol. 1994;24:17001707.[Abstract]
20.
Abdel-Rahman
AR, Merrill RH, Wooles WR. Gender-related differences in the
baroreceptor reflex control of heart rate in normotensive humans.
J Appl Physiol. 1994;77:606613.
21.
Imholz BP,
Wieling W, van Montfrans GA, Wesseling KH. Fifteen years experience
with finger arterial pressure monitoring: assessment of the
technology. Cardiovasc Res. 1998;38:605616.
22.
Tuininga
YS, Crijns HJGM, Brouwer J, van den Berg MP, int Veld AJM, Mulder G,
Lie KI. Evaluation of importance of central effects of atenolol and
metoprolol measured by heart rate variability during mental
performance tasks, physical exercise, and daily life in stable
postinfarct patients.
Circulation. 1995;92:34153423.
23.
Task Force
of the European Society of Cardiology and the North
American Society of Pacing and Electrophysiology. Heart rate
variability: standards of measurement,
physiological interpretation, and clinical use.
Eur Heart J. 1996;17:354381.
24.
Robbe HW,
Mulder LJ, Ruddel H, Langewitz WA, Veldman JB, Mulder G. Assessment of
baroreceptor reflex sensitivity by means of spectral analysis.
Hypertension. 1987;10:538543.
25. Lefrandt JD, Hoogenberg K, van Roon AM, Dullaart RP, Gans RO, Smit AJ. Baroreflex sensitivity is depressed in microalbuminuric type I diabetic patients at rest and during sympathetic manoeuvres. Diabetologia. 1999;42:13451349.[Medline] [Order article via Infotrieve]
26.
Maestri R,
Pinna GD, Mortara A, La Rovere MT, Tavazzi L. Assessing baroreflex
sensitivity in post-myocardial infarction patients: comparison of
spectral and phenylephrine techniques.
J Am Coll Cardiol. 1998;31:344351.
27. Parati G, Frattola A, Omboni S, Mancia G, Di Rienzo M. Analysis of heart rate and blood pressure variability in the assessment of autonomic regulation in arterial hypertension. Clin Sci (Colch). 1996;91(suppl):129132.
28.
Heijden-Spek
JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HA, van Bortel LM. Effect
of age on brachial artery wall properties differs from the aorta and is
gender dependent: a population study.
Hypertension. 2000;35:637642.
29. Sator MO, Joura EA, Gruber DM, Obruca A, Zeisler H, Egarter C, Huber JC. Non-invasive detection of alterations of the carotid artery in pregnant women with high-frequency ultrasound. Ultrasound Obstet Gynecol. 1999;13:260262.[Medline] [Order article via Infotrieve]
30.
Koh KK,
Cardillo C, Bui MN, Hathaway L, Csako G, Waclawiw MA, Panza JA, Cannon
RO III. Vascular effects of estrogen and
cholesterol-lowering therapies in
hypercholesterolemic postmenopausal women.
Circulation. 1999;99:354360.
31. Benetos A, Safar ME. Response to the cold pressor test in normotensive and hypertensive patients. Am J Hypertens. 1991;4(pt 1):627629.
32. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet. 1998;351:478484.[Medline] [Order article via Infotrieve]
33.
Bigger JT
Jr, Fleiss JL, Steinmann RC, Rolnitzky LM, Kleiger RE, Rottman JN.
Frequency domain measures of heart period variability and mortality
after myocardial infarction.
Circulation. 1992;85:164171.
This article has been cited by other articles:
![]() |
C. Pierce, J. Pecen, and K. J. McLeod Influence of Seated Rocking on Blood Pressure in the Elderly: A Pilot Clinical Study Biol Res Nurs, October 1, 2009; 11(2): 144 - 151. [Abstract] [PDF] |
||||
![]() |
G.-F. Qiao, B.-Y. Li, Y.-J. Lu, Y.-L. Fu, and J. H. Schild 17{beta}-Estradiol restores excitability of a sexually dimorphic subset of myelinated vagal afferents in ovariectomized rats Am J Physiol Cell Physiol, January 1, 2009; 297(3): C654 - C664. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fu, W. Vongpatanasin, and B. D. Levine Neural and Nonneural Mechanisms for Sex Differences in Elderly Hypertension: Can Exercise Training Help? Hypertension, November 1, 2008; 52(5): 787 - 794. [Full Text] [PDF] |
||||
![]() |
B.-Y. Li, G.-F. Qiao, B. Feng, R.-B. Zhao, Y.-J. Lu, and J. H. Schild Electrophysiological and neuroanatomical evidence of sexual dimorphism in aortic baroreceptor and vagal afferents in rat Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1301 - R1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coimbra, L. S. Sanchez, J. M. Potenza, L. V. Rossoni, S. L. Amaral, and L. C. Michelini Is Gender Crucial for Cardiovascular Adjustments Induced by Exercise Training in Female Spontaneously Hypertensive Rats? Hypertension, September 1, 2008; 52(3): 514 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wu, F.-H. Lu, Y.-C. Yang, T.-S. Lin, J.-J. Chen, C.-H. Wu, Y.-H. Huang, and C.-J. Chang Epidemiological Study on the Effect of Pre-Hypertension and Family History of Hypertension on Cardiac Autonomic Function J. Am. Coll. Cardiol., May 13, 2008; 51(19): 1896 - 1901. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abildayeva, J. F. P. Berbee, A. Blokland, P. J. Jansen, F. J. Hoek, O. Meijer, D. Lutjohann, T. Gautier, T. Pillot, J. De Vente, et al. Human apolipoprotein C-I expression in mice impairs learning and memory functions J. Lipid Res., April 1, 2008; 49(4): 856 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Laterza, L. D.N.J. de Matos, I. C. Trombetta, A. M.W. Braga, F. Roveda, M. J.N.N. Alves, E. M. Krieger, C. E. Negrao, and M. U.P.B. Rondon Exercise Training Restores Baroreflex Sensitivity in Never-Treated Hypertensive Patients Hypertension, June 1, 2007; 49(6): 1298 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Lipsitz, I. Iloputaife, M. Gagnon, D. K. Kiely, and J. M. Serrador Enhanced Vasoreactivity and Its Response to Antihypertensive Therapy in Hypertensive Elderly Women Hypertension, March 1, 2006; 47(3): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Foley, P. J. Mueller, E. M. Hasser, and C. M. Heesch Hindlimb unloading and female gender attenuate baroreflex-mediated sympathoexcitation Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1440 - R1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Ricardo, M. B. de Almeida, B. A. Franklin, and C. G. S. Araujo Initial and Final Exercise Heart Rate Transients: Influence of Gender, Aerobic Fitness, and Clinical Status Chest, January 1, 2005; 127(1): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Homma and C. Grahame-Clarke Editorial Comment--Myocardial Damage in Patients With Subarachnoid Hemorrhage Stroke, February 1, 2004; 35(2): 552 - 553. [Full Text] [PDF] |
||||
![]() |
M. H. Parker A Review of Cardiovascular Disease and Treatment Differences in Women Journal of Pharmacy Practice, June 1, 2003; 16(3): 157 - 163. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |